Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets

References

• Benabid AL. Deep brain stimulation for Parkinson’s disease. Curr. Opin. Neurobiol.13(6), 696–706 (2003).
   PubMed Web of Science ®Google Scholar
• Benabid AL, Chabardes S, Seigneuret E et al. Functional neurosurgery: past, present, and future. Clin. Neurosurg.52, 265–270 (2005).
   Google Scholar
• Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med.355(9), 896–908 (2006).
   PubMed Web of Science ®Google Scholar
• Follett KA, Weaver FM, Stern M et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med.362(22), 2077–2091 (2010).
   PubMed Web of Science ®Google Scholar
• Weaver FM, Follett K, Stern M et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA301(1), 63–73 (2009).
   PubMed Web of Science ®Google Scholar
• Williams A, Gill S, Varma T et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol.9(6), 581–591.
   Google Scholar
• Okun MS, Fernandez HH, Wu SS et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann. Neurol.65(5), 586–595 (2009).
   PubMed Web of Science ®Google Scholar
• Okun MS, Fernandez HH, Rodriguez RL, Foote KD. Identifying candidates for deep brain stimulation in Parkinson’s disease: the role of the primary care physician. Geriatrics62(5), 18–24 (2007).
   PubMed Web of Science ®Google Scholar
• Okun MS, Foote KD. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch. Neurol.62(4), 533–536 (2005).
   PubMedGoogle Scholar
• Okun MS, Tagliati M, Pourfar M et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch. Neurol.62(8), 1250–1255 (2005).
   PubMed Web of Science ®Google Scholar
• Witt K, Daniels C, Reiff J et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol.7(7), 605–614 (2008).
   PubMed Web of Science ®Google Scholar
• Zahodne LB, Okun MS, Foote KD et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J. Neurol.256(8), 1321–1329 (2009).
   PubMed Web of Science ®Google Scholar
• Hariz MI, Krack P, Alesch F et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J. Neurol. Neurosurg. Psychiatry79(6), 694–699 (2008).
   PubMed Web of Science ®Google Scholar
• Okun MS, Vitek JL. Lesion therapy for Parkinson’s disease and other movement disorders: update and controversies. Mov. Disord.19(4), 375–389 (2004).
   PubMed Web of Science ®Google Scholar
• Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science249(4975), 1436–1438 (1990).
   PubMed Web of Science ®Google Scholar
• Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol.8(1), 67–81 (2009).
   PubMed Web of Science ®Google Scholar
• Moro E, Hamani C, Poon YY et al. Unilateral pedunculopontine stimulation improves falls in Parkinson’s disease. Brain133(Pt 1), 215–224 (2010).
   PubMed Web of Science ®Google Scholar
• Stefani A, Lozano AM, Peppe A et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain130(Pt 6), 1596–1607 (2007).
   PubMed Web of Science ®Google Scholar
• Yelnik J. PPN or PPD, what is the target for deep brain stimulation in Parkinson’s disease? Brain130(Pt 9), e79 (2007).
   PubMed Web of Science ®Google Scholar
• Goff LK, Jouve L, Melon C, Salin P. Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson’s disease. Parkinsonism Relat. Disord.15(Suppl. 3), S167–S170 (2009).
   PubMedGoogle Scholar
• Plaha P, Khan S, Gill SS. Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J. Neurol. Neurosurg. Psychiatry79(5), 504–513 (2008).
   PubMed Web of Science ®Google Scholar
• Taba HA, Wu SS, Foote KD et al. A closer look at unilateral vs bilateral DBS: results of the National Institutes of Health COMPARE cohort. J. Neurosurg. DOI: 10.3171/2010.8.JNS10312 (2010) (Epub ahead of print).
   Google Scholar
• Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage47(Suppl. 2), T53–T57 (2009).
   PubMed Web of Science ®Google Scholar
• Mikos A, Pavon J, Bowers D et al. Factors related to extended hospital stays following deep brain stimulation for Parkinson’s disease. Parkinsonism Relat. Disord.16(5), 324–328 (2010).
   PubMedGoogle Scholar
• Morrell M. Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures? Curr. Opin. Neurol.19(2), 164–168 (2006).
   PubMed Web of Science ®Google Scholar
• Bronte-Stewart H, Barberini C, Koop MM, Hill BC, Henderson JM, Wingeier B. The STN β-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation. Exp. Neurol.215(1), 20–28 (2009).
   PubMed Web of Science ®Google Scholar
• Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology60(1), 78–81 (2003).
   PubMedGoogle Scholar
• Okun MS, Foote KD. Enough is enough: moving on to deep brain stimulation in patients with fluctuating Parkinson disease. Arch. Neurol.66(6), 778–780 (2009).
   Google Scholar
• Schupbach WM, Agid Y. Psychosocial adjustment after deep brain stimulation in Parkinson’s disease. Nat. Clin. Pract. Neurol.4(2), 58–59 (2008).
   PubMedGoogle Scholar
• Schupbach WM, Maltete D, Houeto JL et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology68(4), 267–271 (2007).
   PubMed Web of Science ®Google Scholar
• Haq I, Foote KD, Okun MS. Is earlier better? What do we mean when we advocate for early DBS in Parkinson disease? Appl. Neurol.24–31 (2008).
   Google Scholar
• Charles PD, Gill CE, Davis TL, Konrad PE, Benabid AL. Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat. Clin. Pract. Neurol.4(8), 424–426 (2008).
   PubMedGoogle Scholar
• Okun MS, Foote KD. A mnemonic for Parkinson disease patients considering DBS: a tool to improve perceived outcome of surgery. Neurologist10(5), 290 (2004).
   Google Scholar
• Alberts JL, Hass CJ, Vitek JL, Okun MS. Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp. Neurol.214(1), 1–5 (2008).
   PubMed Web of Science ®Google Scholar
• Alberts JL, Okun MS, Vitek JL. The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson’s patients. Parkinsonism Relat. Disord.14(6), 481–488 (2008).
   PubMed Web of Science ®Google Scholar
• Tabbal SD, Ushe M, Mink JW et al. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Exp. Neurol.211(1), 234–242 (2008).
   Google Scholar
• Zahodne LB, Okun MS, Foote KD et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clin. Neuropsychol.23(3), 385–405 (2009).
   PubMed Web of Science ®Google Scholar
• York MK, Dulay M, Macias A et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry79(7), 789–795 (2008).
   PubMed Web of Science ®Google Scholar
• Mikos A, Bowers D, Noecker AM et al. Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency. Neuroimage DOI: 10.1016/j.neuroimage.2010.03.068 (2010) (Epub ahead of print).
   Google Scholar
• Burdick AP, Fernandez HH, Foote KD et al. Target specificity for post-DBS anger. Presented at: Movement Disorders, Movement Disorders Society 14th Annual Congress. Buenos Aires, Argentina, 13–17 June (2010).
   Google Scholar
• Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science318(5854), 1309–1312 (2007).
   PubMed Web of Science ®Google Scholar
• Ballanger B, van Eimeren T, Moro E et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann. Neurol.66(6), 817–824 (2009).
   PubMed Web of Science ®Google Scholar
• Alberts JL, Voelcker-Rehage C, Hallahan K, Vitek M, Bamzai R, Vitek JL. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson’s disease patients. Brain131(Pt 12), 3348–3360 (2008).
   PubMed Web of Science ®Google Scholar
• Hershey T, Mink JW. Using functional neuroimaging to study the brain’s response to deep brain stimulation. Neurology66(8), 1142–1143 (2006).
   Google Scholar
• Hershey T, Wu J, Weaver PM et al. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp. Neurol.210(2), 402–408 (2008).
   PubMed Web of Science ®Google Scholar
• Okun MS, Fernandez HH, Pedraza O et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology63(1), 161–163 (2004).
   PubMed Web of Science ®Google Scholar
• Okun MS, Fernandez HH, Foote KD, Murphy TK, Goodman WK. Avoiding deep brain stimulation failures in Tourette syndrome. J. Neurol. Neurosurg. Psychiatry79(2), 111–112 (2008).
   PubMedGoogle Scholar
• Schupbach M, Gargiulo M, Welter ML et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology66(12), 1811–1816 (2006).
   PubMed Web of Science ®Google Scholar
• Okun MS, Fogel A, Skoblar B et al. Patient centered outcomes for deep BRAIN stimulation. Presented at: 60th Annual Meeting of the American Academy of Neurology. Chicago, IL, USA, 12–19 April (2008).
   Google Scholar
• Follett K, Weaver F, Stern M et al. Multisite randomized trial of deep brain stimulation. Arch. Neurol.62(10), 1643–1644 (2005).
   PubMedGoogle Scholar
• Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD). Mov. Disord.14(4), 572–584 (1999).
   PubMed Web of Science ®Google Scholar
• Tabbal SD, Revilla FJ, Mink JW et al. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson’s disease. Neurosurgery61(3 Suppl.), 119–127 (2007).
   Google Scholar
• Limousin P, Krack P, Pollak P et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med.339(16), 1105–1111 (1998).
   PubMed Web of Science ®Google Scholar
• Voon V, Krack P, Lang AE et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain131(Pt 10), 2720–2728 (2008).
   PubMed Web of Science ®Google Scholar